Live Breaking News & Updates on ப்ராஸ்டேட் ஆரோக்கியம்

Stay updated with breaking news from ப்ராஸ்டேட் ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Boston Scientific Corp (BSX) Q1 2021 Earnings Call Transcript


Operator
Good morning and welcome to the Boston Scientific First Quarter 2021 Financial Results Conference Call. [Operator Instructions]
I would now like to turn the conference over to Susan Lisa, Vice President, Investor Relations. Please go ahead.
Susie Lisa
Vice President, Investor Relations
Thank you, Andrew. Good morning everyone and thanks for joining us. With me on today s call are Mike Mahoney, Chairman and Chief Executive Officer and Dan Brennan, Executive Vice President and Chief Financial Officer.
We issued a press release earlier this morning announcing our Q1 2021 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release, as well as reconciliations of the non-GAAP measures used in today s call, to the Investor Relations section of our website under the heading Financials and Filings. ....

United States , Ken Stein , Ian Meredith , Dan Brennan , Michaelf Mahoney , Mike Mahoney , Susan Lisa , Spaceoar Vue Hydrogel , Specialty Pharmaceuticals , Prostate Health , Boston Scientific Corp , Pelvic Health , Boston Scientific First Quarter , Results Conference , Vice President , Chief Executive Officer , Executive Vice President , Chief Financial , Investor Relations , Chief Medical Officers , Lumenis Surgical , Risk Factors , Chief Executive , Vercise Genus Deep Brain Stimulation , Investor Day , Middle East Africa ,

Follow the Money: Spatial Omics, CAR-NK Cells, AI-Powered Biology


December 21, 2020
December 21, 2020 | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more.
$170M: Israeli ‘Digital Health First’ VC Firm
OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spearhead the fund’s expansion into the region’s market. OTV is the only venture capital fund in Israel whose primary focus is digital health, specializing in supporting their portfolio companies reach maturity, refine execution, tackle regulatory hurdles and ensure a global imprint on validated products. Over the course of the past five years, OTV has prioritized investment in di ....

United States , Argyll And Bute , United Kingdom , Ulf Landegren , Jonathan Tisch , Sujit Nair , Robert Valenzuela , John Shoffner , Jasont Gammack , Asia Pacific , Andreessen Horowitz , David Shaw , Avinash Reddy , Oncolytic Immunotherapies , Intervenn Biosciences , Sherlock Biosciences , Carl Henric Svanberg , Andreas Ehn , Steven Kaplan , Kevin Love , Michael Palese , Intuitive Investments Group , Seegene Medical Foundation , Israeli Digital Health First Vc Firm , Brainbox Solutions , United Kingdom Investment Firm For Life Sciences ,